{
  "pmcid": "10997181",
  "sha256": "a3a28cae38e5801b8982b066d65d0902aa426f5b861735d03db436f5af33be4d",
  "timestamp_utc": "2025-11-09T15:13:58.349760+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.869241634437532,
    "reading_ease": 24.968523625357335,
    "word_count": 313
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "antibiotics after an aPPendectomy In Complex appendicitis trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Patients with complex appendicitis (age ≥ 8 years) were randomly allocated to 2 days or 5 days of intravenous antibiotics after appendectomy."
      },
      "Participants": {
        "score": 2,
        "evidence": "Patients with complex appendicitis (age ≥ 8 years) were randomly allocated to 2 days or 5 days of intravenous antibiotics after appendectomy. Patient inclusion lasted from June 2017 to June 2021 in 15 Dutch hospitals."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients with complex appendicitis (age ≥ 8 years) were randomly allocated to 2 days or 5 days of intravenous antibiotics after appendectomy."
      },
      "Objective": {
        "score": 1,
        "evidence": "To compare costs for 2 days versus 5 days of postoperative antibiotics within the antibiotics after an aPPendectomy In Complex appendicitis trial."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary trial endpoint was a composite endpoint of infectious complications and mortality within 90 days."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Patients with complex appendicitis (age ≥ 8 years) were randomly allocated to 2 days or 5 days of intravenous antibiotics after appendectomy."
      },
      "Blinding": {
        "score": 3,
        "evidence": "This was a pragmatic, open-label, multicenter clinical trial powered for noninferiority."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Patient inclusion lasted from June 2017 to June 2021 in 15 Dutch hospitals."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "In total, 1005 patients were evaluated in the “intention-to-treat” analysis: 502 patients were allocated to the 2-day group and 503 to the 5-day group."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The mean difference in overall societal costs was – €625 (95% CI: –€ 958 to –€ 278) to the advantage of the 2-day group."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 20,
    "max_score": 25
  }
}